N. Anthony Coles, M.D.

TONY COLES, M.D., has served as the Cerevel Therapeutics chairperson of the board of directors since December 2018 and previously was also the chief executive officer of Cerevel from September 2019 to June 2023. Prior to joining Cerevel, Dr. Coles co-founded and served as the chairperson and chief executive officer of Yumanity Therapeutics, a biotechnology company focused on transforming drug discovery for neurodegenerative diseases. Before co-founding Yumanity Therapeutics, Dr. Coles served as the chairperson and chief executive officer of TRATE Enterprises, LLC, a privately-held company. Previously, Dr. Coles served as president, chief executive officer and chairperson of the board of Onyx Pharmaceuticals, Inc. until its acquisition by Amgen. Prior to joining Onyx Pharmaceuticals, he was president, chief executive officer and a member of the board of directors of NPS Pharmaceuticals, Inc. Before joining NPS Pharmaceuticals, Dr. Coles was senior vice president of commercial operations at Vertex Pharmaceuticals Inc., and earlier, held several executive positions at Bristol-Myers Squibb Company and positions of increasing responsibility at Merck & Co., Inc. In addition to having previously served as a director of Onyx and NPS, Dr. Coles was formerly a director of CRISPR Therapeutics AG, Laboratory Corporation of America Holdings, Campus Crest Communities, Inc. and McKesson Corporation. He also previously served as a member of the Harvard Medical School Board of Fellows. Dr. Coles currently serves on the board of directors of Regeneron Pharmaceuticals, Inc. and is a member of the Board of Trustees for Johns Hopkins University. He is also a member of the Council for the Smithsonian’s National Museum of African American History and Culture in Washington, D.C.; a member of the Board of Trustees of The Metropolitan Museum of Art in New York; and a member of the Board of Directors of the Council on Foreign Relations, an independent, non-partisan membership organization, think tank and publisher. In 2022, Dr. Coles was inducted into the American Academy of Arts & Sciences.

Dr. Coles earned his bachelor’s degree at Johns Hopkins University, a medical degree from Duke University, and a master’s degree in public health from Harvard University. He completed his cardiology and internal medicine training at Massachusetts General Hospital and was a research fellow at Harvard Medical School.